Eubiologics Co Ltd (206650)

Currency in KRW
8,650
-190(-2.15%)
Closed·
206650 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
8,5908,830
52 wk Range
6,95017,700
Key Statistics
Bid/Ask
8,660.00 / 8,680.00
Prev. Close
8,650
Open
8,710
Day's Range
8,590-8,830
52 wk Range
6,950-17,700
Volume
152.96K
Average Volume (3m)
115.3K
1-Year Change
-32.2631%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
206650 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Earnings

Latest Release
Nov 13, 2026
EPS / Forecast
875.00 / --
Revenue / Forecast
47.9B / --
EPS Revisions
Last 90 days

206650 Income Statement

Compare 206650 to Peers and Sector

Metrics to compare
206650
Peers
Sector
Relationship
P/E Ratio
-−14.5x−0.2x
PEG Ratio
-−0.120.00
Price/Book
1.5x1.6x2.6x
Price / LTM Sales
-4.0x2.7x
Upside (Analyst Target)
-0.0%72.2%
Fair Value Upside
Unlock20.0%12.4%Unlock

EuBiologics Co., Ltd., a biopharmaceutical company, focuses on developing vaccines against global pandemic and bacterial vaccines primarily in South Korea. It offers inactivated oral cholera vaccine under the Euvichol, Euvichol-Plus, and Euvichol-S names; and EuCorVac-19, a recombinant protein vaccine. The company also provides EcML that is used as a vaccine adjuvant, directly activating antigen presenting cell expressing TLR 4 agonist, stimulating the production of cytokines and co-stimulatory molecules. In addition, it offers carrier protein vaccine under the rCRM197 name; and biopharmaceutical contract research and manufacturing, and contract testing services. Further, the company engages in the development of and support for the manufacturing technologies of biomedicines. The company was founded in 2010 and is headquartered in Seoul, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.56M4.26%13.41B
Other Institutional Investors
7.67M20.88%65.77B
Public Companies & Retail Investors
27.51M74.86%235.79B
Total
36.75M100.00%314.97B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BioNote, Inc.20.83%7,656,49565,616,162
Vanguard Capital Management, LLC2.93%1,075,7779,219,409

People Also Watch

24,550
043260
-5.94%
44,100
004490
-5.36%
421,500
002960
-3.21%
42,300
025540
-5.16%
68,500
000990
-9.75%

FAQ

What Is the Eubiologics (206650) Stock Price Today?

The Eubiologics stock price today is 8,650 KRW.

What Stock Exchange Does Eubiologics Trade On?

Eubiologics is listed and trades on the KOSDAQ.

What Is the Stock Symbol for Eubiologics?

The stock symbol for Eubiologics is "206650."

What Is the Eubiologics Market Cap?

As of today, Eubiologics market cap is 317.91B KRW.

From a Technical Analysis Perspective, Is 206650 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Eubiologics Stock Split?

Eubiologics has split 1 times.

What is the current trading status of Eubiologics (206650)?

As of Nov 20, 2026, Eubiologics (206650) is trading at a price of 8,650 KRW, with a previous close of 8,650 KRW. The stock has fluctuated within a day range of 8,590 KRW to 8,830 KRW, while its 52-week range spans from 6,950 KRW to 17,700 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.